These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28931839)

  • 1. Multiwell capillarity-based microfluidic device for the study of 3D tumour tissue-2D endothelium interactions and drug screening in co-culture models.
    Virumbrales-Muñoz M; Ayuso JM; Olave M; Monge R; de Miguel D; Martínez-Lostao L; Le Gac S; Doblare M; Ochoa I; Fernandez LJ
    Sci Rep; 2017 Sep; 7(1):11998. PubMed ID: 28931839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery.
    Agarwal P; Wang H; Sun M; Xu J; Zhao S; Liu Z; Gooch KJ; Zhao Y; Lu X; He X
    ACS Nano; 2017 Jul; 11(7):6691-6702. PubMed ID: 28614653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.
    Howes AL; Richardson RD; Finlay D; Vuori K
    PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures.
    Mosaad E; Chambers K; Futrega K; Clements J; Doran MR
    BMC Cancer; 2018 May; 18(1):592. PubMed ID: 29793440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bladder cancer microenvironment simulation system based on a microfluidic co-culture model.
    Liu PF; Cao YW; Zhang SD; Zhao Y; Liu XG; Shi HQ; Hu KY; Zhu GQ; Ma B; Niu HT
    Oncotarget; 2015 Nov; 6(35):37695-705. PubMed ID: 26462177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidic modelling of the tumor microenvironment for anti-cancer drug development.
    Shang M; Soon RH; Lim CT; Khoo BL; Han J
    Lab Chip; 2019 Jan; 19(3):369-386. PubMed ID: 30644496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release.
    Sabhachandani P; Sarkar S; Mckenney S; Ravi D; Evens AM; Konry T
    J Control Release; 2019 Feb; 295():21-30. PubMed ID: 30550941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment.
    Bai J; Tu TY; Kim C; Thiery JP; Kamm RD
    Oncotarget; 2015 Nov; 6(34):36603-14. PubMed ID: 26474384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotaxis-driven assembly of endothelial barrier in a tumor-on-a-chip platform.
    Aung A; Theprungsirikul J; Lim HL; Varghese S
    Lab Chip; 2016 May; 16(10):1886-98. PubMed ID: 27097908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional culture models to study drug resistance in breast cancer.
    Fisher MF; Rao SS
    Biotechnol Bioeng; 2020 Jul; 117(7):2262-2278. PubMed ID: 32297971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
    Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
    Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time and non-invasive impedimetric monitoring of cell proliferation and chemosensitivity in a perfusion 3D cell culture microfluidic chip.
    Lei KF; Wu MH; Hsu CW; Chen YD
    Biosens Bioelectron; 2014 Jan; 51():16-21. PubMed ID: 23920091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidic system for modelling 3D tumour invasion into surrounding stroma and drug screening.
    Du Z; Mi S; Yi X; Xu Y; Sun W
    Biofabrication; 2018 Jun; 10(3):034102. PubMed ID: 29786602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-physiological microenvironment simulation on chip to evaluate drug resistance of different loci in tumour mass.
    Wang S; Mao S; Li M; Li HF; Lin JM
    Talanta; 2019 Jan; 191():67-73. PubMed ID: 30262100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single cell dual adherent-suspension co-culture micro-environment for studying tumor-stromal interactions with functionally selected cancer stem-like cells.
    Chen YC; Zhang Z; Fouladdel S; Deol Y; Ingram PN; McDermott SP; Azizi E; Wicha MS; Yoon E
    Lab Chip; 2016 Aug; 16(15):2935-45. PubMed ID: 27381658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of intercellular communication between breast cancer cells and adipose-derived stem cells via passive diffusion in a two-layer microfluidic device.
    Rahman SM; Campbell JM; Coates RN; Render KM; Byrne CE; Martin EC; Melvin AT
    Lab Chip; 2020 Jun; 20(11):2009-2019. PubMed ID: 32379852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid formation of size-controllable multicellular spheroids via 3D acoustic tweezers.
    Chen K; Wu M; Guo F; Li P; Chan CY; Mao Z; Li S; Ren L; Zhang R; Huang TJ
    Lab Chip; 2016 Jul; 16(14):2636-43. PubMed ID: 27327102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidics 3D gel-island chip for single cell isolation and lineage-dependent drug responses study.
    Zhang Z; Chen YC; Cheng YH; Luan Y; Yoon E
    Lab Chip; 2016 Jul; 16(13):2504-2512. PubMed ID: 27270563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance.
    Breslin S; O'Driscoll L
    Oncotarget; 2016 Jul; 7(29):45745-45756. PubMed ID: 27304190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of a microfluidic model of the tumour microenvironment.
    Ayuso JM; Virumbrales-Muñoz M; Lacueva A; Lanuza PM; Checa-Chavarria E; Botella P; Fernández E; Doblare M; Allison SJ; Phillips RM; Pardo J; Fernandez LJ; Ochoa I
    Sci Rep; 2016 Oct; 6():36086. PubMed ID: 27796335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.